Safety and Immunogenicity of a Single Dose of BNT162b2 COVID-19 mRNA Vaccine in a Warfarin-Treated Protein S Deficient Patient: A Case Report and Literature Review

Patients with protein S (PS) deficiency possibly have a higher risk of developing severe COVID-19 disease. Therefore, vaccination against SARS-CoV-2 infections is recommended for PS-deficient patients. However, there are limited data regarding the safety and immunogenicity of the currently available...

Descripción completa

Detalles Bibliográficos
Autores principales: Cucunawangsih, Cucunawangsih, Wijaya, Ratna Sari, Lugito, Nata Pratama Hardjo, Suriapranata, Ivet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779118/
https://www.ncbi.nlm.nih.gov/pubmed/36547235
http://dx.doi.org/10.3390/hematolrep14040051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779118/
https://www.ncbi.nlm.nih.gov/pubmed/36547235
http://dx.doi.org/10.3390/hematolrep14040051

Ejemplares similares